Home » FDA Warns About More Hospira Syringes
FDA Warns About More Hospira Syringes
The overfilling of Hospira’s Carpuject ready-to-use drug syringes previously reported for two injectable painkillers may also be seen in at least 13 other products, the FDA said. The affected products — syringes prefilled with drugs ranging from an antinausea agent to benzodiazepines and beta-blockers — have not been recalled, but the FDA has advised healthcare workers to visually inspect any Carpuject prefilled syringes before using them to ensure that they do not contain more drug than the label indicates.
MedPage Today
MedPage Today
Upcoming Events
-
07May
-
14May
-
30May